

EXTRA

	Start and end by framing

		Maybe use Close the loop stuff from Rutgers talk?

	Compare the burial sections

	Ebola rR estimates?

	ADD

		Decent "approximation" section

		A _treatment_ ethics slide; but make sure you understand it (read article?)

	Think more Small/large stuff (eliminate? add some dialogue?)

	Final Conclusions

----------------------------------------------------------------------

Modeling Ebola

\vfill

Tachikawa infectious boot camp,  2019

\vfill

Jonathan Dushoff, McMaster University

\vfill

\url{https://github.com/dushoff/Generation_talks}

\vfill


----------------------------------------------------------------------

SEC Dynamic modeling of infectious diseases

----------------------------------------------------------------------

EXTRA Infectious diseases

FIG webpix/flu_masks.jpg

----------------------------------------------------------------------

EXTRA Infectious diseases

FIG webpix/burial_team.jpg

----------------------------------------------------------------------

Models

BCC

CFIG webpix/flat.png

NCC

	A model is a simplified view of the world

	Allows linking between assumptions and outcomes

EC

----------------------------------------------------------------------

Dynamic models

SUBH Connect scales

WIDEFIG SIR_model_family/sir.three.pdf

Small-scale events $\displaystyle \Leftrightarrow$ Large-scale patterns and outcomes

----------------------------------------------------------------------

Measles

SUBH Dynamic modeling connects scales

BCC

CFIG my_images/trans.jpg

NCC

CFIG Disease_data/ewmeas.Rout-0.pdf

EC

----------------------------------------------------------------------

Ebola

SUBH Dynamic modeling connects scales

BCC

CFIG webpix/ebola_ward.jpg

NCC

CFIG WA_Ebola_Outbreak/liberia.npc.tsplot.Rout-1.pdf

EC

----------------------------------------------------------------------

Statistics and theory

	Dynamical models are required to bridge scales

	Statistical frameworks are required to interpret noisy data

	We need tools that can incorporate dynamical mechanisms into
	frameworks that allow statistical inference

	Simple dynamical theories allow clearer interpretation and inspire
	better techniques

----------------------------------------------------------------------

Questions

BC

	Your model is not reality

	But it may help you answer a specific research question

	The model you use should be tailored to your question

		What are the relevant details?

NC

CFIG webpix/flat.png

EC

----------------------------------------------------------------------

SEC Early Ebola models

----------------------------------------------------------------------

TSS Process error and observation error

	\textbf{Observation error}: we don't observe the world perfectly

	\textbf{Process error}: we think our dynamical system has a fundamental random component

		This is usually the only way to model processes where we treat
		individuals as individuals

	Doing both of these things is hard

----------------------------------------------------------------------

Lekone and Finkenstadt, 2006

	Modeled a small 1995 Ebola outbreak in DR Congo

	Used latent variables to consider both process error and observation error

	Result: More realistic model $\implies$ more uncertainty

	CREDIT DOI: 10.1111/j.1541-0420.2006.00609.x

----------------------------------------------------------------------

SS Projection models

----------------------------------------------------------------------

The CDC projection

	Meltzer 2014 estimated $>1$ million cases by ``Jan 20, 2015'' unless
	effective action was taken

	Model contained contained many compartments for infected people

		disease stage, linkage to treatment

	Very crude handling of contact patterns, susceptibles

----------------------------------------------------------------------

FIG Ebola_math/straw.Rout.pdf

----------------------------------------------------------------------

Projection models

	Wrong level of detail

	But they did address a question:

		Does the West Africa Ebola epidemic have the potential to be a global
		crisis?

----------------------------------------------------------------------

The epidemic

BCC

FIG Ebola_math/WHO/liberia150429.npc.tsplot.Rout-3.pdf

NCC

FIG Ebola_math/WHO/sierraLeone150429.npc.tsplot.Rout-3.pdf

EC

----------------------------------------------------------------------

Reproductive number

	Expected number of new cases per cases
	
	$\Rx = \beta D S/N$

		Disease increases iff $\Rx>1$

	$\Ro = \beta D$

		Disease is usually eliminated when $\Ro<1$

----------------------------------------------------------------------

Simple conclusions

	Tendency to oscillate

	Threshold for spread (or control)

	Very large or very small number of people affected

		by a single epidemic

		at equilibrium

	Unless \Ro\ happens to be very near 1.

----------------------------------------------------------------------

Ebola outbreaks

	Before 2014, most Ebola outbreaks were either
	
		very small, or

		pretty large (compared to some estimate of population at risk in
		a remote village)

	More or less consistent with simple picture

----------------------------------------------------------------------

Predicted outbreak size

BCC

	Simple models argue that outbreaks should (almost always) be:

		Very small (sub-critical), or

		Very large (at the scale of the population)

NCC

CFIG subclinical/ebola.curve.Rout-0.pdf

EC

----------------------------------------------------------------------

SEC Some simple models

----------------------------------------------------------------------

SS Burial transmission

----------------------------------------------------------------------

Ebola outbreak

FIG my_images/weitz_full.pdf

$C \approx 1 \,\mathrm{month}$.

----------------------------------------------------------------------

Post-death transmission and safe burial

BC

	What proportion of Ebola spread occurs before vs.\ after death?

	Highly context dependent

		Funeral practices, disease knowledge

	What if it's more than we think?

		Disease spreads slower?

	CREDIT Weitz and Dushoff \emph{Scientific Reports} 5:8751.

NC

FIG webpix/burial_team.jpg

EC

----------------------------------------------------------------------

Standard disease model 

WIDEFIG SIR_model_family/seir.four.pdf

----------------------------------------------------------------------

Disease model including post-death transmission

WIDEFIG SIR_model_family/seird.four.pdf

----------------------------------------------------------------------

Disease model including post-death transmission

WIDEFIG SIR_model_family/brides.four.pdf

----------------------------------------------------------------------

Scenarios

FIG my_images/weitz_full.pdf

----------------------------------------------------------------------

Ebola burial example

	Burial transmission increases the mean generation interval

		Increases estimate of $\Rx$

	\ldots increases variation

		Decreases estimate of $\Rx$

	Based on filtered mean, we know that the net effect of shifting transmission
	later, must be to increase the estimate

----------------------------------------------------------------------

Summary

	Different parameters can produce indistinguishable early dynamics

	More after-death transmission implies

		Higher \Ro

		Larger epidemics

		Larger importance of safe burials

	$r = \mathrm{strength}\times\mathrm{generation~speed}$

----------------------------------------------------------------------

TSS Dynamic effects of sub-clinical infections

	People with no history of clinical Ebola illness have Ebola-specific
	antibodies:

		In forests where animals carry Ebola

		In places where past Ebola outbreaks have occurred

	What if $\approx$ 50% of people infected by the virus mount an
	effective immune response with \emph{sub-clinical} infection?

	CREDIT Bellan et al. \emph{Lancet} 384:1499--1500, October 2014

----------------------------------------------------------------------

Standard epidemic model

WIDEFIG SIR_model_family/sir.three.pdf

----------------------------------------------------------------------

Add an exposed class

WIDEFIG SIR_model_family/seir.four.pdf

----------------------------------------------------------------------

Add asymptomatic immunity

WIDEFIG SIR_model_family/raise.four.pdf

----------------------------------------------------------------------

Simplify

WIDEFIG SIR_model_family/arisen.four.pdf

----------------------------------------------------------------------

What is the effect of sub-clinical immunity?

	What do we already know?

		Parameters and starting conditions?

		Incidence time series?

----------------------------------------------------------------------


Ebola \emph{cases}

BC

CFIG subclinical/base.tsplots.Rout-0.png

NC

CFIG subclinical/base.tsplots.Rout-1.png

EC

----------------------------------------------------------------------

Ebola \emph{infections}

BC

CFIG subclinical/base.tsplots.Rout-2.png

NC

CFIG subclinical/base.tsplots.Rout-3.png

EC

----------------------------------------------------------------------

Estimation

	Indirect evidence

		Not enough information, and too many complications

			Population structure, changes through time

	Direct evidence

		Easy: how common is sub-clinical infection?

			More evidence is available now

			\ldots but not as much as we expected.

		Hard: how protected are people who recover from it?

----------------------------------------------------------------------

SEC Forecasting

----------------------------------------------------------------------

Compartment model approaches

FIG webpix/sherif.jpg

----------------------------------------------------------------------

Discrete-time renewal equation

FIG webpix/discrete_renewal.jpg

CREDIT https://doi.org/10.1016/j.epidem.2017.02.011

----------------------------------------------------------------------

Why do we see medium-sized epidemics?

BC

	why.txt

NC

CFIG subclinical/ebola.curve.Rout-0.pdf

EC

----------------------------------------------------------------------

Relevant detail

	The things we are good at estimating and modeling may not be sufficient to
	forecast Ebola spread

	We don't know enough about:

		contact structures

		beliefs and behaviours

----------------------------------------------------------------------

Report what we don't know?

FIG Ebola_math/WHO/sierraLeone150429.npc.tsplot.Rout-3.pdf

----------------------------------------------------------------------

TSEC Ethics

BC

	History of abuse $\to$ strong rules

	In general, you can't put public good ahead of participant
	interests

	It's hard to achieve clinical equipoise -- would \emph{you} want to
	be in the control arm?

	CREDIT Bellan et al., \emph{BMJ} 2014;349:g7518

NC

FIG my_images/equipoise.jpg

EC

----------------------------------------------------------------------

Vaccine trials

	What are the \emph{ethics} of controlled trials in the middle of a
	deadly epidemic?

	What are the \emph{logistics} of controlled trials on the down-slope
	of an epidemic?

----------------------------------------------------------------------

TSS Ethics

BC

	History of abuse $\to$ strong rules

	In general, you can't put public good ahead of participant
	interests

	It's hard to achieve clinical equipoise -- would \emph{you} want to
	be in the control arm?

	CREDIT Bellan et al., \emph{BMJ} 2014;349:g7518

NC

FIG my_images/equipoise.jpg

EC
----------------------------------------------------------------------

SUB The statistical power and validity of Ebola vaccine trials 

----------------------------------------------------------------------

Randomized controlled trials

	The gold standard of medical evidence

	A plan is made, and then participants are individually and randomly
	assigned to \textbf{treatment} and \textbf{control} groups

	Control groups sometimes get something that is meant to be good for
	their health, too

		E.g., a meningococcal vaccine

----------------------------------------------------------------------

Stepped-wedge controlled trials (SWCT)

	Sometimes it's unethical to delay vaccination (or other treatment)
	to participants

	You still can't necessarily vaccinate everyone at once

	It may be possible to evaluate efficacy by randomizing the
	\emph{order} in which people are vaccinated

	This is a relatively \emph{fragile} idea

		Not as powerful as RCT

		If RCT is not ethical, then it's also not ethical to make
		logistical concessions to study objectives

----------------------------------------------------------------------

Simulated incidence

FIG my_images/projection.pdf

----------------------------------------------------------------------

Vaccine rollout scenarios

FIG my_images/rollout.pdf

----------------------------------------------------------------------

Statistical validity

FIG my_images/validity.pdf

----------------------------------------------------------------------

Statistical power

FIG my_images/TrialPower.png

----------------------------------------------------------------------

Summary

	Spatiotemporal variation undercuts SWCT

		Reduces power

		Reduces or eliminates ethical advantages

	RCTs surprisingly robust to all kinds of issues

	Permutation tests can rescue of statistical validity 

	Changing landscapes

		Hard to do an Ebola vaccine trial when incidence is very high or
		very low

----------------------------------------------------------------------

Conclusions

ADD
